Advanced search
Publication Cover
International Medical Case Reports Journal Volume 16, 2023 - Issue
Submit an article Journal homepage
241
Views
0
CrossRef citations to date
0
Altmetric
Case reports

A Case of Young Obese Heart Failure Patient Using Multidisciplinary Treatment Centered on the Fantastic Four Improved Cardio Ankle Vascular Index and Cardiac Function

Yuki Ikeda1 Department of Internal Medicine, Toho University Sakura Medical Center, Chiba, JapanORCID Iconhttps://orcid.org/0000-0002-1237-7337View further author information
ORCID Icon,
Masahiro Iwakawa1 Department of Internal Medicine, Toho University Sakura Medical Center, Chiba, JapanView further author information
,
Hajime Kiyokawa1 Department of Internal Medicine, Toho University Sakura Medical Center, Chiba, JapanView further author information
,
Takahiro Nakagami1 Department of Internal Medicine, Toho University Sakura Medical Center, Chiba, JapanView further author information
,
Shinya Kanzaki2 Department of Rehabilitation, Toho University Sakura Medical Center, Chiba, JapanView further author information
,
Akihiro Ogawa2 Department of Rehabilitation, Toho University Sakura Medical Center, Chiba, JapanView further author information
,
Tsuyoshi Tabata3 Department of Clinical Functional Physiology, Toho University Sakura Medical Center, Chiba, JapanView further author information
,
Mao Takahashi1 Department of Internal Medicine, Toho University Sakura Medical Center, Chiba, JapanORCID Iconhttps://orcid.org/0000-0003-2808-2020View further author information
ORCID Icon,
Toshio Kinoshita1 Department of Internal Medicine, Toho University Sakura Medical Center, Chiba, Japan;3 Department of Clinical Functional Physiology, Toho University Sakura Medical Center, Chiba, JapanORCID Iconhttps://orcid.org/0000-0002-8692-9923View further author information
ORCID Icon &
Kazuhiro Shimizu1 Department of Internal Medicine, Toho University Sakura Medical Center, Chiba, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9896-0939View further author information
ORCID Icon show all
Pages 545-549 | Received 03 Jul 2023, Accepted 07 Sep 2023, Published online: 14 Sep 2023

References

  • Bauersachs J. Heart failure drug treatment: the fantastic four. Eur Heart J. 2021;42(6):681–683. doi:10.1093/eurheartj/ehaa1012
  • McMurray JJ, Packer M, Desai AS, et al.; PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993–1004. doi:10.1056/NEJMoa1409077
  • Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb. 2006;13(2):101–107. doi:10.5551/jat.13.101
  • Hayashi K, Yamamoto T, Takahara A, Shirai K. Clinical assessment of arterial stiffness with cardio-ankle vascular index: theory and applications. J Hypertens. 2015;33(9):1742–1757. doi:10.1097/HJH.0000000000000651
  • Shirai K, Song M, Suzuki J, et al. Contradictory effects of β1- and α1-aderenergic receptor blockers on cardio-ankle vascular stiffness index (CAVI) - CAVI independent of blood pressure. J Atheroscler Thromb. 2011;18(1):49–55. doi:10.5551/jat.3582
  • Ng M, Fleming T, Robinson M, et al. Global, regional and national prevalence of overweight and obesity in children and adults 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–781. doi:10.1016/S0140-6736(14)60460-8
  • Tromp J, Paniagua SMA, Lau ES, et al. Age dependent associations of risk factors with heart failure: pooled population based cohort study. BMJ. 2021;372:n461. doi:10.1136/bmj.n461
  • Shimizu K, Yamamoto T, Takahashi M, Sato S, Noike H, Shirai K. Effect of nitroglycerin administration on cardio-ankle vascular index. Vasc Health Risk Manag. 2016;12:313–319. eCollection 2016. doi:10.2147/VHRM.S106542
  • Tabata T, Shimizu K, Morinaga Y, et al. The relationship between cardio-ankle vascular index and left atrial phasic function in hypertensive patients with preserved ejection fraction. Front Med Technol. 2021;3:724089. eCollection 2021. doi:10.3389/fmedt.2021.724089
  • Tabata T, Sato S, Ohno R, et al. Cardio-vascular interaction evaluated by speckle-tracking echocardiography and cardio-ankle vascular index in hypertensive patients. Int J Mol Sci. 2022;23(22):14469. doi:10.3390/ijms232214469
  • Packer M, Anker SD, Butler J, et al.; EMPEROR-Reduced Trial Committees and Investigators. Empagliflozin in patients with heart failure, reduced ejection fraction, and Volume overload: EMPEROR-reduced trial. J Am Coll Cardiol. 2021;77(11):1381–1392. doi:10.1016/j.jacc.2021.01.033
  • Solomon SD, de Boer RA, DeMets D, et al. Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial. Eur J Heart Fail. 2021;23(7):1217–1225. doi:10.1002/ejhf.2249
  • McMurray JJ, Packer M, Desai AS, et al.; PARADIGM-HF Committees and Investigators. Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF). Eur J Heart Fail. 2013;15(9):1062–1073. doi:10.1093/eurjhf/hft052

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.